Wuhan Coronavirus Health Advisory
In view of the rapidly evolving situation of the Wuhan Coronavirus, Fullerton Health is closely monitoring the development and has put in place appropriate precautionary measures.
January 28, 2020
In view of the rapidly evolving situation of the Wuhan Coronavirus, Fullerton Health is closely monitoring the development and has put in place appropriate precautionary measures.
At the World Economic Forum (WEF) Annual Meeting, a multi-sectoral group of partners today launched a new initiative – called Ending Workplace Tuberculosis (TB)...
What's the driving force behind Fullerton Health's rapid growth and expansion from a home-grown healthcare company in Singapore to a conglomerate operating in 9 markets with over 550 self-owned facilities and a network of over 10,000 in Asia Pacific.
Fullerton Health, a leading vertically integrated healthcare platform in Asia Pacific, is pleased to announce the appointment of Mr Ho Kuen Loon as the new...
Fullerton Health Australia Pty Limited (“Fullerton Health Australia” or the “Company”), part of Fullerton Health, announced today...
Asalus Corporation (operating under the trade name “Intellicare”), part of Fullerton Health, announced today that it has entered into a collaboration agreement...
SINGAPORE, and SALT LAKE CITY, USA, April 16, 2019 – Fullerton Health, a leading vertically integrated healthcare platform in the Asia Pacific region with a proven track record of providing clients with seamless service offerings through customized healthcare management and administration, has partnered with Health Catalyst, Inc., a leading provider of data and analytics technology […]
Fullerton Health is pleased to announce that Jeff Chen has been appointed Group Chief Innovation Officer and Head of Capital Markets, based in Hong Kong.
Fullerton Health today announced the retirement of Tam Chee Chong, Fullerton Health’s Group Chief Financial Officer...
SINGAPORE, 18 February 2019 – Fullerton Health is pleased to announce that Jeff Chen has been appointed Group Chief Innovation Officer and Head of Capital Markets, based in Hong Kong. As Group Chief Innovation Officer and Head of Capital Markets, Jeff will serve on the Leadership Team and report to David Sin, Co-Founder and Group […]
This is Fullerton China’s first investment in the specialty hospitals sector, following which Fullerton China will become...
Partnership to fully integrate online and offline healthcare services in the region by combining the complementary...
Singapore, 18 May 2018 – Fullerton Health, a leading vertically integrated healthcare platform in Asia Pacific, is pleased to announce that following the announcement on 11 December 2017, the pre-conditions for completion of the acquisition of a 60% stake in the Intellicare Group have now been satisfied and completion has taken place. The acquisition marks […]
Fullerton Health, a leading managed care provider in Asia Pacific, announced today that Fullerton Health China Limited...
December 11, 2017 – Fullerton Health today announced that it has entered into agreements to acquire a 60% stake in the Intellicare Group
Fullerton’s maiden S$100 million bond issuance guaranteed by Credit Guarantee...
Fullerton Health, a leading provider of corporate healthcare solutions across Asia Pacific, today announced that it has acquired Healthscope's medical centre operations ("HMC")
Fullerton Health, a leading provider of corporate healthcare solutions across Asia Pacific, today successfully priced the issue of a perpetual bond...